These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 30832710

  • 21. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab].
    Tsanyan ME, Torgashina AV, Aleksandrova EN, Soloviev SK, Nasonov EL.
    Ter Arkh; 2013; 85(5):53-9. PubMed ID: 23819340
    [Abstract] [Full Text] [Related]

  • 22. Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients.
    Jesus AA, Campos LM, Liphaus BL, Carneiro-Sampaio M, Mangueira CL, Rosseto EA, Silva CA, Scheinberg M.
    Rev Bras Reumatol; 2012 Dec; 52(6):976-81. PubMed ID: 23223707
    [Abstract] [Full Text] [Related]

  • 23. Anti-C1q antibodies in systemic lupus erythematosus.
    Orbai AM, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcón GS, Gordon C, Merrill J, Fortin PR, Bruce IN, Isenberg DA, Wallace DJ, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke AE, Aranow CB, Manzi S, Urowitz MB, Gladman DD, Kalunian KC, Costner MI, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, Van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG, Sigler L, Hameed S, Pham N, Brey R, Weisman MH, McGwin G, Magder LS, Petri M.
    Lupus; 2015 Jan; 24(1):42-9. PubMed ID: 25124676
    [Abstract] [Full Text] [Related]

  • 24. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
    Kianmehr N, Khoshmirsafa M, Shekarabi M, Falak R, Haghighi A, Masoodian M, Seif F, Omidi F, Shirani F, Dadfar N.
    J Immunoassay Immunochem; 2021 Jul 04; 42(4):406-423. PubMed ID: 33788670
    [Abstract] [Full Text] [Related]

  • 25. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
    Smykał-Jankowiak K, Niemir ZI, Polcyn-Adamczak M.
    Pol Arch Med Wewn; 2011 Sep 04; 121(9):287-95. PubMed ID: 21860370
    [Abstract] [Full Text] [Related]

  • 26. C1q complement component and -antibodies reflect SLE activity and kidney involvement.
    Horák P, Hermanová Z, Zadrazil J, Ciferská H, Ordeltová M, Kusá L, Zurek M, Tichý T.
    Clin Rheumatol; 2006 Jul 04; 25(4):532-6. PubMed ID: 16311713
    [Abstract] [Full Text] [Related]

  • 27. Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis.
    Soliman AF, Egailla SE, Abdel-Gawad ER, Mansour AI, ElKhouly TH, Mahgoub MY.
    Egypt J Immunol; 2016 Jan 04; 23(1):107-116. PubMed ID: 28502158
    [Abstract] [Full Text] [Related]

  • 28. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.
    Arthritis Rheum; 2011 Aug 04; 63(8):2436-44. PubMed ID: 21506094
    [Abstract] [Full Text] [Related]

  • 29. Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis.
    Fang QY, Yu F, Tan Y, Xu LX, Wu LH, Liu G, Shao FM, Zhao MH.
    Nephrol Dial Transplant; 2009 Jan 04; 24(1):172-8. PubMed ID: 18697800
    [Abstract] [Full Text] [Related]

  • 30. Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus.
    Moura CG, Lima I, Barbosa L, Athanazio D, Reis E, Reis M, Burlingame RW, Santiago MB.
    J Clin Lab Anal; 2009 Jan 04; 23(1):19-23. PubMed ID: 19140207
    [Abstract] [Full Text] [Related]

  • 31. Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement.
    ElGendi SS, El-Sherif WT.
    Egypt J Immunol; 2009 Jan 04; 16(1):135-48. PubMed ID: 20726330
    [Abstract] [Full Text] [Related]

  • 32. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study.
    Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D'Cruz DP, Isenberg DA, Rahman A.
    Arthritis Res Ther; 2009 Oct 14; 11(5):R154. PubMed ID: 19828047
    [Abstract] [Full Text] [Related]

  • 33. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
    Jaekell HP, Trabandt A, Grobe N, Werle E.
    Lupus; 2006 Oct 14; 15(6):335-45. PubMed ID: 16830879
    [Abstract] [Full Text] [Related]

  • 34. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
    Gutiérrez-Adrianzén OA, Koutouzov S, Mota RM, das Chagas Medeiros MM, Bach JF, de Holanda Campos H.
    J Rheumatol; 2006 Aug 14; 33(8):1538-44. PubMed ID: 16783863
    [Abstract] [Full Text] [Related]

  • 35. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
    Farid EM, Hassan AB, Abalkhail AA, El-Agroudy AE, Arrayed SA, Al-Ghareeb SM.
    Saudi J Kidney Dis Transpl; 2013 Nov 14; 24(6):1271-9. PubMed ID: 24231503
    [Abstract] [Full Text] [Related]

  • 36. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
    Elshweikh SA, Elkhouly RM, Shaalan MM, Shorbagy SH.
    Egypt J Immunol; 2014 Nov 14; 21(2):49-59. PubMed ID: 25812352
    [Abstract] [Full Text] [Related]

  • 37. Anti-DNA and anti-nucleosome antibody affinity--a mirror image of lupus nephritis?
    Williams RC, Malone C, Blood B, Silvestris F.
    J Rheumatol; 1999 Feb 14; 26(2):331-46. PubMed ID: 9972967
    [Abstract] [Full Text] [Related]

  • 38. Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus.
    Kumar A, Gupta R, Varghese T, Pande RM, Singal VK, Garg OP.
    Indian J Med Res; 1999 Dec 14; 110():190-3. PubMed ID: 10701298
    [Abstract] [Full Text] [Related]

  • 39. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.
    Meyer OC, Nicaise-Roland P, Cadoudal N, Grootenboer-Mignot S, Palazzo E, Hayem G, Dieudé P, Chollet-Martin S.
    Arthritis Res Ther; 2009 Dec 14; 11(3):R87. PubMed ID: 19515233
    [Abstract] [Full Text] [Related]

  • 40. Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.
    Dieker J, Schlumberger W, McHugh N, Hamann P, van der Vlag J, Berden JH.
    Mol Immunol; 2015 Nov 14; 68(1):20-4. PubMed ID: 26597199
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.